Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Sweet

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Transactions of the American Neurological Association|January 1, 1974
Piribedil--an oral dopamine agonist for treatment of Parkinson's diseaseR D Sweet, C Wasterlain, F H McDowell
International Journal of Neurology|January 1, 1975
Parkinsonism, levodopa, and intelligenceA Loranger, R D Sweet, H Goodell, et al.
Annals of Internal Medicine|November 1, 1971
Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatmentJ E Lee, R D Sweet, F H McDowell
Clinical Pharmacology and Therapeutics|January 1, 1972
Methyldopa as an adjunct to levodopa treatment of Parkinson's diseaseR D Sweet, J E Lee, F H McDowell
The Mount Sinai Journal of Medicine, New York|July 1, 1980
Thalamic infarction producing aphasiaJ A Cohen, C E Gelfer, R D Sweet
Clinical Pharmacology and Therapeutics|December 1, 1974
Piribedil, a dopamine agonist, in Parkinson's diseaseR D Sweet, C G Wasterlain, F H McDowell
Neurology|May 1, 1976
Piribedil: its synergistic effect in multidrug regimens for parkinsonismJ S Feigenson, R D Sweet, F H McDowell
Archives of General Psychiatry|December 1, 1974
Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazineR D Sweet, R Bruun, E Shapiro, et al.
Neurology|May 1, 1972
Enhanced response to low doses of levodopa after withdrawal from chronic treatmentR D Sweet, J E Lee, H E Speigel, et al.
Archives of Neurology|August 1, 1975
Treatment of "on-off effect" with a dopa decarboxylase inhibitorR D Sweet, F H McDowell, C G Wasterlain, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Transactions of the American Neurological Association|January 1, 1974
Piribedil--an oral dopamine agonist for treatment of Parkinson's diseaseR D Sweet, C Wasterlain, F H McDowell
International Journal of Neurology|January 1, 1975
Parkinsonism, levodopa, and intelligenceA Loranger, R D Sweet, H Goodell, et al.
Annals of Internal Medicine|November 1, 1971
Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatmentJ E Lee, R D Sweet, F H McDowell
Clinical Pharmacology and Therapeutics|January 1, 1972
Methyldopa as an adjunct to levodopa treatment of Parkinson's diseaseR D Sweet, J E Lee, F H McDowell
The Mount Sinai Journal of Medicine, New York|July 1, 1980
Thalamic infarction producing aphasiaJ A Cohen, C E Gelfer, R D Sweet
Clinical Pharmacology and Therapeutics|December 1, 1974
Piribedil, a dopamine agonist, in Parkinson's diseaseR D Sweet, C G Wasterlain, F H McDowell
Neurology|May 1, 1976
Piribedil: its synergistic effect in multidrug regimens for parkinsonismJ S Feigenson, R D Sweet, F H McDowell
Archives of General Psychiatry|December 1, 1974
Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazineR D Sweet, R Bruun, E Shapiro, et al.
Neurology|May 1, 1972
Enhanced response to low doses of levodopa after withdrawal from chronic treatmentR D Sweet, J E Lee, H E Speigel, et al.
Archives of Neurology|August 1, 1975
Treatment of "on-off effect" with a dopa decarboxylase inhibitorR D Sweet, F H McDowell, C G Wasterlain, et al.
Pageof 3